Agency Information Collection Activities; Submission for OMB Review; Comment Request; Authorization Request Forms/Certification/Letter of Medical Necessity, 8029-8030 [2020-02730]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 29 / Wednesday, February 12, 2020 / Notices
lotter on DSKBCFDHB2PROD with NOTICES
expressly represented that the manager
qualifies as a QPAM or relies on the
QPAM class exemption (PTE 84–14). A
Covered Plan does not include an
ERISA-covered plan or IRA to the extent
the UBS QPAM has expressly
disclaimed reliance on QPAM status or
PTE 84–14 in entering into a contract,
arrangement, or agreement with the
ERISA-covered plan or IRA.
(d) The term ‘‘FX Misconduct’’ means
the conduct engaged in by UBS
personnel described in Exhibit 1 of the
Plea Agreement (Factual Basis for
Breach) entered into between UBS and
the U.S. Department of Justice Criminal
Division, on May 20, 2015 in connection
with Case Number 3:15–cr–00076–RNC
filed in the U.S. District Court for the
District of Connecticut.
(e) The term ‘‘UBS QPAM’’ means
UBS Asset Management (Americas) Inc.,
UBS Realty Investors LLC, UBS Hedge
Fund Solutions LLC, UBS O’Connor
LLC, and any future entity within the
Asset Management or the Global Wealth
Management Americas U.S. divisions of
UBS that qualifies as a ‘‘qualified
professional asset manager’’ (as defined
in Section VI(a) of PTE 84–14) 15 and
that relies on the relief provided by PTE
84–14, and with respect to which UBS
is an ‘‘affiliate’’ (as defined in Part VI(d)
of PTE 84–14). The term ‘‘UBS QPAM’’
excludes UBS Securities Japan, the
entity implicated in the criminal
conduct that is the subject of the 2013
Conviction; UBS, the entity implicated
in the criminal conduct that is the
subject of the 2017 Conviction and
implicated in the criminal conduct of
UBS and UBS France that is the subject
of the 2019 French Conviction; and UBS
France, the entity implicated in the
criminal conduct of UBS and UBS
France that is the subject of the 2019
French Conviction.
(f) The term ‘‘UBS’’ means UBS AG.
(g) The term ‘‘UBS France’’ means
‘‘UBS (France) S.A.,’’ a wholly-owned
subsidiary of UBS incorporated under
the laws of France.
(h) The term ‘‘UBS Securities Japan’’
means UBS Securities Japan Co. Ltd, a
wholly-owned subsidiary of UBS
incorporated under the laws of Japan.
(i) All references to ‘‘the 2019 French
Conviction Date’’ means February 20,
2019;
15 In general terms, a QPAM is an independent
fiduciary that is a bank, savings and loan
association, insurance company, or investment
adviser that meets certain equity or net worth
requirements and other licensure requirements and
that has acknowledged in a written management
agreement that it is a fiduciary with respect to each
plan that has retained the QPAM.
VerDate Sep<11>2014
17:03 Feb 11, 2020
Jkt 250001
(j) All references to ‘‘the 2017
Conviction Date’’ means January 10,
2017.
(k) The term ‘‘Exemption Period’’
means the five-year period beginning on
February 20, 2020 and ending on
February 20, 2025;
(l) The term ‘‘Plea Agreement’’ means
the Plea Agreement (including Exhibits
1 and 3 attached thereto) entered into
between UBS and the U.S. Department
of Justice Criminal Division, on May 20,
2015 in connection with Case Number
3:15–cr–00076–RNC filed in the U.S.
District Court for the District of
Connecticut.
Effective Date: This exemption will be
in effect for a period of five years
beginning on February 20, 2020.
Signed at Washington, DC, this 7th day of
February, 2020.
Lyssa Hall,
Director, Office of Exemption Determinations,
Employee Benefits Security Administration,
U.S. Department of Labor.
[FR Doc. 2020–02834 Filed 2–11–20; 8:45 am]
BILLING CODE 4510–29–P
DEPARTMENT OF LABOR
Office of the Secretary
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request;
Authorization Request Forms/
Certification/Letter of Medical
Necessity
Notice of availability; request
for comments.
ACTION:
The Department of Labor
(DOL) is submitting the Office of
Worker’s Compensation Programs
(OWCP) sponsored information
collection request (ICR) titled,
‘‘Authorization Request Forms/
Certification/Letter of Medical
Necessity’’ to the Office of Management
and Budget (OMB) for review and
reinstatement, without change, in
accordance with the Paperwork
Reduction Act of 1995 (PRA). Public
comments on the ICR are invited.
DATES: The OMB will consider all
written comments that agency receives
on or before March 13, 2020.
ADDRESSES: A copy of this ICR with
applicable supporting documentation;
including a description of the likely
respondents, proposed frequency of
response, and estimated total burden
may be obtained free of charge from the
RegInfo.gov website at https://
www.reginfo.gov/public/do/
PRAViewICR?ref_nbr=201906-1240-001
(this link will only become active on the
SUMMARY:
PO 00000
Frm 00113
Fmt 4703
Sfmt 4703
8029
day following publication of this notice)
or by contacting Frederick Licari by
telephone at 202–693–8073, TTY 202–
693–8064, (these are not toll-free
numbers) or by email at DOL_PRA_
PUBLIC@dol.gov.
Submit comments about this request
by mail to the Office of Information and
Regulatory Affairs, Attn: OMB Desk
Officer for DOL–OWCP, Office of
Management and Budget, Room 10235,
725 17th Street NW, Washington, DC
20503; by Fax: 202–395–5806 (this is
not a toll-free number); or by email:
OIRA_submission@omb.eop.gov.
Commenters are encouraged, but not
required, to send a courtesy copy of any
comments by mail or courier to the U.S.
Department of Labor—OASAM, Office
of the Chief Information Officer, Attn:
Departmental Information Compliance
Management Program, Room N1301,
200 Constitution Avenue NW,
Washington, DC 20210; or by email:
DOL_PRA_PUBLIC@dol.gov.
FOR FURTHER INFORMATION CONTACT:
Frederick Licari by telephone at 202–
693–8073, TTY 202–693–8064, (these
are not toll-free numbers) or by email at
DOL_PRA_PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION: This ICR
seeks to reinstate PRA authority for the
Authorization Request Forms/
Certification/Letter of Medical Necessity
information collection. The FECA
statute grants OWCP discretion to
provide an injured employee the
‘‘services, appliances, and supplies
prescribed or recommended by a
qualified physician’’ which OWCP
considers ‘‘likely to cure, give relief,
reduce the degree or the period of
disability, or aid in lessening the
amount of the monthly compensation.’’
5 U.S.C. 8103. In other words, OWCP is
mandated to provide medical supplies
and services—including prescription
drugs such as opioids and compounded
drugs—that it considers medically
necessary. The FECA statute and
implementing regulations are not
primarily focused on managing doctor/
patient decisions relating to medication
therapy and, with the exception of few
limitations on fentanyl (an opioid) and
other controlled substances, the FECA
program policy on pharmacy benefits
has generally been a policy of payment
for prescribed medications in
accordance with a fee schedule based on
a percentage of the average wholesale
price (AWP) for drugs identified by a
National Drug Code (NDC). See 20 CFR
10.809. To this end, the FECA program
has a prior authorization policy (based
on medical necessity) for opioid and
compounded drugs utilizing the preauthorization authority already
E:\FR\FM\12FEN1.SGM
12FEN1
lotter on DSKBCFDHB2PROD with NOTICES
8030
Federal Register / Vol. 85, No. 29 / Wednesday, February 12, 2020 / Notices
contained in its regulations at 20 CFR
10.310(a) and § 10.800(b). Information
collected on the CA–26 and the CA–27,
require an injured worker’s treating
physician to answer a number of
questions about the prescribed opioids
and/or compounded drugs and certify
that they are medically necessary to
treat the work-related injury. The
responses to the questions on the forms
are intended to ensure that treating
physicians have considered non-opioid
and non-compounded drug alternatives,
and are only prescribing the most cost
effective and medically necessary drugs.
The forms also permit OWCP to more
easily track the volume, type, and
characteristics of opioids and
compounded drugs authorized by the
FECA program. The forms serve as a
means for injured workers to continue
receiving opioids and compounded
drugs only where medically necessary
and simultaneously give OWCP greater
oversight in monitoring their
appropriate use and gather additional
data about their use.
This information collection is subject
to the PRA. A Federal agency generally
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless the OMB
under the PRA approves it and displays
a currently valid OMB Control Number.
In addition, notwithstanding any other
provisions of law, no person shall
generally be subject to penalty for
failing to comply with a collection of
information that does not display a
valid Control Number. See 5 CFR
1320.5(a) and 1320.6. The DOL obtains
OMB approval for this information
collection under Control Number 1240–
0055.
OMB authorization for an ICR cannot
be for more than three (3) years without
renewal. The DOL seeks to reinstate
PRA authorization for this information
collection for three (3) more years,
without any change to existing
requirements. For additional substantive
information about this ICR, see the
related notice published in the Federal
Register on November 6, 2019 (84 FR
59842).
Interested parties are encouraged to
send comments to the OMB, Office of
Information and Regulatory Affairs at
the address shown in the ADDRESSES
section within thirty-(30) days of
publication of this notice in the Federal
Register. In order to help ensure
appropriate consideration, comments
should mention OMB Control Number
1240–0055. The OMB is particularly
interested in comments that:
• Evaluate whether the proposed
collection of information is necessary
VerDate Sep<11>2014
17:03 Feb 11, 2020
Jkt 250001
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility:
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used.
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Agency: DOL–OWCP.
Title of Collection: Authorization
Request Forms/Certification/Letter of
Medical Necessity.
OMB Control Number: 1240–0055.
Affected Public: Individuals or
households.
Total Estimated Number of
Respondents: 45,600.
Total Estimated Number of
Responses: 45,600.
Total Estimated Annual Time Burden:
22,800 hours.
Total Estimated Annual Other Costs
Burden: $0.
Authority: 44 U.S.C. 3507(a)(1)(D).
Dated: February 4, 2020.
Frederick Licari,
Departmental Clearance Officer.
[FR Doc. 2020–02730 Filed 2–11–20; 8:45 am]
NEIGHBORHOOD REINVESTMENT
CORPORATION
Sunshine Act Meetings; Regular Board
of Directors Meeting
& DATE: 2:00 p.m., Thursday,
February 20, 2020.
PLACE: NeighborWorks America—
Gramlich Boardroom, 999 North Capitol
Street NE, Washington, DC 20002.
STATUS: Open (with the exception of
Executive Session).
MATTERS TO BE CONSIDERED: The General
Counsel of the Corporation has certified
that in his opinion, one or more of the
exemptions set forth in 5 U.S.C.
552(b)(2) and (4) permit closure of the
following portion(s) of this meeting:
• Report from CEO
TIME
Agenda
I. Call to Order
Frm 00114
Fmt 4703
Rutledge Simmons,
EVP & General Counsel/Corporate Secretary.
[FR Doc. 2020–02947 Filed 2–10–20; 4:15 pm]
BILLING CODE 7570–02–P
NUCLEAR REGULATORY
COMMISSION
[Docket No. 52–025; NRC–2008–0252]
Vogtle Electric Generating Plant, Unit
3; Hearing Opportunity Associated
With Inspections, Tests, Analyses, and
Acceptance Criteria
Nuclear Regulatory
Commission.
ACTION: Notice of intended operation;
opportunity for hearing on conformance
with the acceptance criteria in the
combined license; and associated
orders.
AGENCY:
By letter dated January 13,
2020, Southern Nuclear Operating
Company (SNC) informed the U.S.
Nuclear Regulatory Commission (NRC)
that its scheduled date for initial
loading of fuel into the reactor for
Vogtle Electric Generating Plant (VEGP)
Unit 3 is November 23, 2020. The
Atomic Energy Act of 1954, as amended
(AEA), and NRC regulations provide the
public with an opportunity to request a
hearing regarding the licensee’s
conformance with the acceptance
criteria in the combined license for the
facility. This document announces the
public’s opportunity to request a
hearing and includes orders imposing
procedures for the hearing process.
DATES: A request for a hearing must be
filed by April 13, 2020. Any potential
party as defined in section 2.4 of title 10
of the Code of Federal Regulations (10
CFR), who believes access to Sensitive
Unclassified Non-Safeguards
Information (SUNSI) or Safeguards
Information (SGI) is necessary for
SUMMARY:
BILLING CODE 4510–CH–P
PO 00000
II. Welcome Susan Ifill, COO
III. Approval of Minutes
IV. Executive Session: External Audit
Presentation
V. Executive Session: Report from CEO
VI. Action Item Audit Committee Report
VII. Action Item FY20 Final Budget
VIII. Discussion Item Completion of
FY19 Annual Ethics Review
IX. Discussion Item Governance
Working Group Report
X. Management Program Background
and Updates
XI. Adjournment
CONTACT PERSON FOR MORE INFORMATION:
Rutledge Simmons, EVP & General
Counsel/Secretary, (202) 760–4105;
Rsimmons@nw.org.
Sfmt 4703
E:\FR\FM\12FEN1.SGM
12FEN1
]]>Agencies
[Federal Register Volume 85, Number 29 (Wednesday, February 12, 2020)]
[Notices]
[Pages 8029-8030]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02730]
-----------------------------------------------------------------------
DEPARTMENT OF LABOR
Office of the Secretary
Agency Information Collection Activities; Submission for OMB
Review; Comment Request; Authorization Request Forms/Certification/
Letter of Medical Necessity
ACTION: Notice of availability; request for comments.
-----------------------------------------------------------------------
SUMMARY: The Department of Labor (DOL) is submitting the Office of
Worker's Compensation Programs (OWCP) sponsored information collection
request (ICR) titled, ``Authorization Request Forms/Certification/
Letter of Medical Necessity'' to the Office of Management and Budget
(OMB) for review and reinstatement, without change, in accordance with
the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR
are invited.
DATES: The OMB will consider all written comments that agency receives
on or before March 13, 2020.
ADDRESSES: A copy of this ICR with applicable supporting documentation;
including a description of the likely respondents, proposed frequency
of response, and estimated total burden may be obtained free of charge
from the RegInfo.gov website at https://www.reginfo.gov/public/do/PRAViewICR?ref_nbr=201906-1240-001 (this link will only become active
on the day following publication of this notice) or by contacting
Frederick Licari by telephone at 202-693-8073, TTY 202-693-8064, (these
are not toll-free numbers) or by email at [email protected].
Submit comments about this request by mail to the Office of
Information and Regulatory Affairs, Attn: OMB Desk Officer for DOL-
OWCP, Office of Management and Budget, Room 10235, 725 17th Street NW,
Washington, DC 20503; by Fax: 202-395-5806 (this is not a toll-free
number); or by email: [email protected]. Commenters are
encouraged, but not required, to send a courtesy copy of any comments
by mail or courier to the U.S. Department of Labor--OASAM, Office of
the Chief Information Officer, Attn: Departmental Information
Compliance Management Program, Room N1301, 200 Constitution Avenue NW,
Washington, DC 20210; or by email: [email protected].
FOR FURTHER INFORMATION CONTACT: Frederick Licari by telephone at 202-
693-8073, TTY 202-693-8064, (these are not toll-free numbers) or by
email at [email protected].
SUPPLEMENTARY INFORMATION: This ICR seeks to reinstate PRA authority
for the Authorization Request Forms/Certification/Letter of Medical
Necessity information collection. The FECA statute grants OWCP
discretion to provide an injured employee the ``services, appliances,
and supplies prescribed or recommended by a qualified physician'' which
OWCP considers ``likely to cure, give relief, reduce the degree or the
period of disability, or aid in lessening the amount of the monthly
compensation.'' 5 U.S.C. 8103. In other words, OWCP is mandated to
provide medical supplies and services--including prescription drugs
such as opioids and compounded drugs--that it considers medically
necessary. The FECA statute and implementing regulations are not
primarily focused on managing doctor/patient decisions relating to
medication therapy and, with the exception of few limitations on
fentanyl (an opioid) and other controlled substances, the FECA program
policy on pharmacy benefits has generally been a policy of payment for
prescribed medications in accordance with a fee schedule based on a
percentage of the average wholesale price (AWP) for drugs identified by
a National Drug Code (NDC). See 20 CFR 10.809. To this end, the FECA
program has a prior authorization policy (based on medical necessity)
for opioid and compounded drugs utilizing the pre-authorization
authority already
[[Page 8030]]
contained in its regulations at 20 CFR 10.310(a) and Sec. 10.800(b).
Information collected on the CA-26 and the CA-27, require an injured
worker's treating physician to answer a number of questions about the
prescribed opioids and/or compounded drugs and certify that they are
medically necessary to treat the work-related injury. The responses to
the questions on the forms are intended to ensure that treating
physicians have considered non-opioid and non-compounded drug
alternatives, and are only prescribing the most cost effective and
medically necessary drugs. The forms also permit OWCP to more easily
track the volume, type, and characteristics of opioids and compounded
drugs authorized by the FECA program. The forms serve as a means for
injured workers to continue receiving opioids and compounded drugs only
where medically necessary and simultaneously give OWCP greater
oversight in monitoring their appropriate use and gather additional
data about their use.
This information collection is subject to the PRA. A Federal agency
generally cannot conduct or sponsor a collection of information, and
the public is generally not required to respond to an information
collection, unless the OMB under the PRA approves it and displays a
currently valid OMB Control Number. In addition, notwithstanding any
other provisions of law, no person shall generally be subject to
penalty for failing to comply with a collection of information that
does not display a valid Control Number. See 5 CFR 1320.5(a) and
1320.6. The DOL obtains OMB approval for this information collection
under Control Number 1240-0055.
OMB authorization for an ICR cannot be for more than three (3)
years without renewal. The DOL seeks to reinstate PRA authorization for
this information collection for three (3) more years, without any
change to existing requirements. For additional substantive information
about this ICR, see the related notice published in the Federal
Register on November 6, 2019 (84 FR 59842).
Interested parties are encouraged to send comments to the OMB,
Office of Information and Regulatory Affairs at the address shown in
the ADDRESSES section within thirty-(30) days of publication of this
notice in the Federal Register. In order to help ensure appropriate
consideration, comments should mention OMB Control Number 1240-0055.
The OMB is particularly interested in comments that:
Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility:
Evaluate the accuracy of the agency's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used.
Enhance the quality, utility, and clarity of the
information to be collected; and
Minimize the burden of the collection of information on
those who are to respond, including through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses.
Agency: DOL-OWCP.
Title of Collection: Authorization Request Forms/Certification/
Letter of Medical Necessity.
OMB Control Number: 1240-0055.
Affected Public: Individuals or households.
Total Estimated Number of Respondents: 45,600.
Total Estimated Number of Responses: 45,600.
Total Estimated Annual Time Burden: 22,800 hours.
Total Estimated Annual Other Costs Burden: $0.
Authority: 44 U.S.C. 3507(a)(1)(D).
Dated: February 4, 2020.
Frederick Licari,
Departmental Clearance Officer.
[FR Doc. 2020-02730 Filed 2-11-20; 8:45 am]
BILLING CODE 4510-CH-P
